Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

B.Brilliant Revelation Comparision Study

University of Pennsylvania · with Siemens Corporation, Corporate Technology · NCT07067788

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18+ · Women only
Healthy volunteers
Accepted
Study type
Observational
Target enrollment
100
US sites recruiting
1
Study start
December 15, 2025
Record last updated
April 24, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

This is an observational study to evaluate the MAMMOMAT B.brilliant system. All diagnostic decisions are made by the treating radiologist based upon standard of care clinical imaging acquired on FDA approved devices

Being studied: Breast Imaging

Conditions: Breast Cancer Screening

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Participants will be ≥ 18 years of age.
  • Participants will be females (sex assigned at birth).
  • Participants will be presenting for clinical diagnostic mammography with suspicious calcifications or calcifications associated with other lesion types
  • Participants must be informed of the investigational nature of this study and be willing to provide written informed consent and participate in this study in accordance with institutional and federal guidelines prior to study-specific procedures.

Exclusion Criteria

  • Females who are breast-feeding will not be eligible for this study
  • Pregnant women will not be included. All females of childbearing potential must attest that they are not pregnant.
  • Inability to tolerate imaging procedures in the opinion of an investigator or treating physician.
  • Any current medical condition, illness, or disorder, as assessed by medical record review and/or self-reported, that is considered by a physician investigator to be a condition that could compromise participant safety or successful participation in the study.

Recruiting US locations

  • Pennsylvania Hospital, Center for Breast Imaging

    Philadelphia, PA 19107

    Site contact: Jessica Nunez · 215-829-3712 · Jessica.Nunez@pennmedicine.upenn.edu

Study contacts (from the official record)

  • Namaijah Faison Clinical Research Coordinator · 215-432-5000 · Namaijah.Faison@pennmedicine.upenn.edu
  • Jessica Nunez Project Manager · 215-829-3712 · Jessica.Nunez@pennmedicine.upenn.edu
B.Brilliant Revelation Comparision Study (NCT07067788) | Bored Studies